Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
H Lasolle, C Cortet, F Castinetti, L Cloix… - European Journal of …, 2017 - academic.oup.com
Objectives Only few retrospective studies have reported an efficacy rate of temozolomide
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
[PDF][PDF] Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
H Lasolle, C Cortet, F Castinetti, L Cloix, P Caron… - …, 2017 - researchgate.net
Objectives: Only few retrospective studies have reported an efficacy rate of temozolomide
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
H Lasolle, C Cortet, F Castinetti, L Cloix… - European Journal of …, 2017 - hal.science
Objectives: Only few retrospective studies have reported an efficacy rate of temozolomide
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas.
H Lasolle, C Cortet, F Castinetti… - European Journal …, 2017 - search.ebscohost.com
Objectives: Only few retrospective studies have reported an efficacy rate of temozolomide
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
H Lasolle, C Cortet, F Castinetti, L Cloix… - European Journal of …, 2017 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objectives</jats: title>< jats: p> Only few retrospective studies
have reported an efficacy rate of temozolomide (TMZ) in pituitary tumors (PT), all around …
have reported an efficacy rate of temozolomide (TMZ) in pituitary tumors (PT), all around …
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas.
H Lasolle, C Cortet, F Castinetti, L Cloix… - European Journal of …, 2017 - europepmc.org
Objectives Only few retrospective studies have reported an efficacy rate of temozolomide
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
H Lasolle, C Cortet, F Castinetti, L Cloix… - European Journal of …, 2017 - inria.hal.science
Objectives: Only few retrospective studies have reported an efficacy rate of temozolomide
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
H Lasolle, C Cortet, F Castinetti… - European journal …, 2017 - pubmed.ncbi.nlm.nih.gov
Objectives Only few retrospective studies have reported an efficacy rate of temozolomide
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
H Lasolle, C Cortet, F Castinetti, L Cloix… - European Journal …, 2017 - u-picardie.hal.science
Objectives: Only few retrospective studies have reported an efficacy rate of temozolomide
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …
(TMZ) in pituitary tumors (PT), all around 50%. However, the long-term survival of treated …